HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 278, Issue 33, 30781-30787, August 15, 2003

This Article Full Text Full Text (PDF) All Versions of this Article: 278/33/30781    most recent M305238200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Palamakumbura, A. H. Articles by Trackman, P. C. Search for Related Content PubMed PubMed Citation Articles by Palamakumbura, A. H. Articles by Trackman, P. C. Social Bookmarking                      What's this?

Autocrine Growth Factor Regulation of Lysyl Oxidase Expression in Transformed Fibroblasts^*

Amitha H. Palamakumbura , Pascal Sommer  and Philip C. Trackman  ¶

From the Boston University Goldman School of Dental Medicine, Division of Oral Biology, Boston, Massachusetts 02118 and Institut de Biologie et Chimie des Protéines, CNRS UMR 5086, Université Claude Bernard, 69367 Lyon Cedex 07 France

Lysyl oxidase catalyzes oxidative deamination of peptidyl-lysine and hydroxylysine residues in collagens and lysine residues in elastin to form peptidyl aldehydes that are required for the formation of covalent cross-links in normal extracellular matrix biosynthesis. Lysyl oxidase in addition has tumor suppressor activity, and phenotypic reversion of transformed cell lines is accompanied by increased lysyl oxidase expression. The mechanism of low expression of lysyl oxidase in tumor cells is unknown. The present study investigates the hypothesis that autocrine growth factor pathways maintain low lysyl oxidase expression levels in c-H-ras-transformed fibroblasts (RS485 cell line). Autocrine pathways were blocked with suramin, a general inhibitor of growth factor receptor binding, and resulted in more than a 10-fold increase in lysyl oxidase expression and proenzyme production. This regulation was found to be reversible and occurred at the transcriptional level determined using lysyl oxidase promoter/reporter gene assays. Function blocking anti-fibroblast growth factor-2 (FGF-2) antibody enhanced lysyl oxidase expression in the absence of suramin. Finally, the addition of FGF-2 to suramin-treated cells completely reversed suramin stimulation of lysyl oxidase mRNA levels. Data support that an FGF-2 autocrine pathway inhibits lysyl oxidase transcription in the tumorigenic-transformed RS485 cell line. This finding may be of therapeutic significance and, in addition, provides a new experimental approach to investigate the mechanism of the tumor suppressor activity of lysyl oxidase.

Received for publication, May 19, 2003

^* This research was supported by NIDCR, National Institutes of Health Grants DE12425, DE12209, and DE11004 (to P. C. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^¶ To whom correspondence should be addressed: Boston University Goldman School of Dental Medicine, Division of Oral Biology, 700 Albany St., W-210, Boston, MA 02118. Tel.: 617-638-4076; Fax: 617-638-5265; E-mail: trackman{at}bu.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Guruvayoorappan and G. Kuttan {beta}-Carotene Inhibits Tumor-Specific Angiogenesis by Altering the Cytokine Profile and Inhibits the Nuclear Translocation of Transcription Factors in B16F-10 Melanoma Cells Integr Cancer Ther, September 1, 2007; 6(3): 258 - 270. [Abstract] [PDF]

				B. Fogelgren, N. Polgar, K. M. Szauter, Z. Ujfaludi, R. Laczko, K. S. K. Fong, and K. Csiszar Cellular Fibronectin Binds to Lysyl Oxidase with High Affinity and Is Critical for Its Proteolytic Activation J. Biol. Chem., July 1, 2005; 280(26): 24690 - 24697. [Abstract] [Full Text] [PDF]

				A. H. Palamakumbura, S. Jeay, Y. Guo, N. Pischon, P. Sommer, G. E. Sonenshein, and P. C. Trackman The Propeptide Domain of Lysyl Oxidase Induces Phenotypic Reversion of Ras-transformed Cells J. Biol. Chem., September 24, 2004; 279(39): 40593 - 40600. [Abstract] [Full Text] [PDF]